What is the duration of action for oxycodone (Oxy IR) immediate release?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Action for Oxycodone Immediate Release (Oxy IR)

Immediate release oxycodone (Oxy IR) has a duration of action of 3-6 hours, with an apparent elimination half-life of 3.5 to 4 hours following oral administration. 1, 2

Pharmacokinetic Profile of Oxycodone IR

  • Oxycodone IR has an onset of action within 10-30 minutes after oral administration 1
  • Peak effects typically occur within 1-2 hours after administration 2
  • The duration of analgesic effect lasts 3-6 hours for immediate release formulations 1, 3
  • The elimination half-life ranges from 3.5 to 4 hours 2
  • It takes approximately 18 to 24 hours to reach steady-state plasma concentrations with regular dosing 2

Clinical Implications

  • Due to its 3-6 hour duration of action, immediate release oxycodone is typically dosed every 4-6 hours for pain management when needed 1, 3
  • For breakthrough pain in patients on controlled-release oxycodone, immediate release formulations provide rescue analgesia within the same timeframe 1
  • When converting from immediate release to controlled release formulations, the total daily dose can be divided into two doses given 12 hours apart 4, 5

Pharmacological Considerations

  • Oxycodone has high oral bioavailability (60-87%) compared to other oral opioids due to lower first-pass metabolism 2, 3
  • The drug is primarily metabolized in the liver via CYP3A4 and CYP2D6 pathways 2
  • Food intake can enhance the extent of absorption (27% increase in AUC) but not the rate, and may delay the time to maximum concentration 2

Special Population Considerations

  • In patients with hepatic impairment, clearance may decrease, potentially extending the duration of action 2
  • Patients with renal impairment may experience increased adverse effects as the drug and its metabolites are primarily excreted via the kidney 2
  • In patients with end-stage liver disease, oxycodone should be avoided according to European Association for the Study of the Liver (EASL) recommendations 1

Comparison with Extended-Release Formulations

  • While immediate release oxycodone lasts 3-6 hours, controlled-release formulations provide 10-12 hours of analgesia 1
  • Extended-release formulations should not be used for as-needed pain relief or for acute pain management 1
  • Immediate release formulations are preferred for dose titration and management of breakthrough pain 1, 6

Common Pitfalls to Avoid

  • Administering immediate release oxycodone more frequently than every 4 hours can lead to accumulation and increased risk of adverse effects 1
  • Crushing or breaking controlled-release formulations can destroy their extended-release properties and lead to rapid absorption, potentially causing overdose 1
  • Immediate release oxycodone should not be used with other CNS depressants without appropriate dose adjustments due to increased risk of respiratory depression 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.